Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Side effects for both medications are similar, primarily gastrointestinal, and can usually be managed through gradual dose escalation and lifestyle adjustments
Even though semaglutide is commonly used for treating type 2 diabetes, it has gained immense acceptance and popularity as a weight loss treatment for eligible patients
Monitoring thyroid function and any changes in symptoms can lead to early intervention and better management of conditions
Summary: GLP-1 receptor agonists are not specifically contraindicated in Crohn's disease, but their use requires careful individualised assessment due to potential gastrointestinal side effects and disease-specific considerations
doi: 10.3390/jcm9020474
.jpg)
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
